SYGNIS Pharma AG Announces Management Board Changes
3/26/2013 9:44:54 AM
More...
|
SYGNIS Pharma AG to Discontinue Ongoing R&D Project, Trim Workforce
12/20/2012 6:40:05 AM
More...
|
Annual General Meeting of SYGNIS Pharma AG Approves Combination of Businesses With X-Pol Biotech
10/18/2012 2:23:14 PM
More...
|
SYGNIS Pharma AG Announces Three Months Results of Fiscal Year 2012/2013
8/14/2012 9:42:19 AM
More...
|
SYGNIS Pharma AG Reports Financial Results for Fiscal Year 2011/2012
7/25/2012 9:26:06 AM
More...
|
SYGNIS Pharma AG and GENETRIX Announce Proposed Combination of Businesses of SYGNIS and GENETRIX' Subsidiary X-Pol
7/18/2012 10:09:04 AM
More...
|
SYGNIS Pharma AG Says Stroke Drug AX200 Failed to Meet Study Goal
12/16/2011 7:56:14 AM
More...
|
Cenix BioScience GmbH Signs RNAi Research Agreement with SYGNIS Pharma AG
11/17/2011 12:12:45 PM
More...
|
SYGNIS Pharma AG Strengthens its KIBRA-Project: First Patents Announced for Europe and the USA
5/5/2011 10:19:00 AM
More...
|
SYGNIS Pharma AG Enters Final Stage with its Phase II Efficacy Study of AX200 for the Treatment of Acute Stroke
3/22/2011 10:38:26 AM
More...
|
|